Both hypodiploidy and deletion of chromosome 13 independently confer poor prognosis in multiple myeloma

British Journal of Haematology

Volumn 118, Issue 4, 2002, Pages 1041-1047

  Fassas, Athanasios B T ^a,b   Spencer, Tray ^a   Sawyer, Jeffrey ^a   Zangari, Maurizio ^a   Lee, Choon Kee ^a   Anaissie, Elias ^a   Muwalla, Firas ^a   Morris, Christopher ^a   Barlogie, Bart ^a   Tricot, Guido ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS AT LITTLE ROCK   (United States)

Author keywords

Deletion chromosome 13; Hypodiploidy; Multiple myeloma; Prognosis

Indexed keywords

ALBUMIN; BETA 2 MICROGLOBULIN; MELPHALAN;

ADULT; ARTICLE; CHROMOSOME 13; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CHROMOSOME NUMBER; CHROMOSOME TRANSLOCATION; CLINICAL TRIAL; CONDITIONING; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIPLOIDY; HUMAN; KARYOTYPE; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; SURVIVAL;

BETA 2-MICROGLOBULIN; CASE-CONTROL STUDIES; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 13; CYTOGENETIC ANALYSIS; DISEASE-FREE SURVIVAL; HUMANS; MIDDLE AGED; MULTIPLE MYELOMA; MULTIVARIATE ANALYSIS; PROGNOSIS; SERUM ALBUMIN; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 18544363372     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03757.x     Document Type: Article

References (37)

1. High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor lymphocyte infusions
2. Prognostic implications of tumor cell DNA and RNA content in multiple myeloma
3. Plasma cell myeloma-new biological insights and advances in therapy
4. Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma
5. Hypodiploidy and 22q11 rearrangements at diagnosis are associated with poor prognosis in patients with multiple myeloma
6. The use of biological variables to predict outcome in multiple myeloma
7. Results of high-dose therapy for 1000 patients with multiple myeloma: Durable complete remissions and superior survival in the absence of chromosome 13 abnormalities
8. The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis
9. The biological significance of the KI-67 growth fraction in multiple myeloma
10. Prognostic implications of DNA aneuploidy in 156 untreated multiple myeloma patients
11. 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma
12. Is flow cytometric DNA content hypodiploidy prognostic in multiple myeloma?
13. Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: Results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol
14. Hypodiploidy with less than 45 chromosomes confers adverse risk in childhood acute lymphoblastic leukemia: A report from the children's cancer group
15. DNA aneuploidy by flow cytometry is an independent prognostic factor in squamous cell carcinoma of the oral cavity
16. Why better prognostic factors for multiple myeloma are needed
17. Improved cytogenetics in multiple myeloma: A study of 151 patients including 117 patients at diagnosis
18. Cellular contents as a marker of human multiple myeloma
19. Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma
20. Combining an allogeneic graft -vs- myeloma effect with high dose autologous stem cell rescue in the treatment of multiple myeloma
21. Detection of hypodiploidy using multiparameter flow cytometric analysis: A prognostic indicator in multiple myeloma
22. Tumor-cell DNA content predicts outcome in children and adolescents with clinical group III embryonal rhabdomyosarcoma
23. Prognostic value of numerical chromosome aberrations in multiple myeloma: A FISH analysis of 15 different chromosomes
24. Hypodiploidy, Ki-67 growth fraction and prognosis of surgically resected lung cancers
25. Tumor DNA content as a prognostic indicator in squamous cell carcinoma of the oral cavity and tongue base
26. Cytogenetic findings in 200 patients with multiple myeloma
27. Prognostic value of cytogenetics in multiple myeloma
28. Hypodiploidy is a major prognostic factor in multiple myeloma
29. Chromosomal analysis in multiple myeloma: Cytogenetic evidence of two different diseases
30. Biclonal and hypodiploid multiple myeloma
31. DNA and RNA flow cytometric study in multiple myeloma: Clinical correlations
32. Flow cytometric DNA analysis and clinical correlations in multiple myeloma
33. Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities
34. Unique role of cytogenetics in the prognosis of patients with myeloma receiving high dose therapy and autotransplants
35. Karyotype in multiple myeloma and plasma cell leukaemia
36. Correlations between karyotype and cytologic findings in multiple myeloma
37. Image analysis in multiple myeloma at diagnosis. Correlation with cytogenetic study